topical Janus kinase (JAK) family inhibitor

approved for atopic dermatitis in JP

from scaffold hop from known JAK inhibitor

J. Med. Chem., Jun. 8, 2020

Japan Tobacco, Osaka, JP

Structure of JAK inhibitor Delgocitinib

JTE-052 (delgocitinib) is a pan-JAK kinase inhibitor approved as a topical ointment for treatment of atopic dermatitis in Japan. The compound has an interesting azetidine-containing diazaspirocycle core and a relatively…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: